Marshall Wace’s MorphoSys MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-264,961
Closed -$4.81M – 3093
2024
Q1
$4.81M Sell
264,961
-61,125
-19% -$904K 0.01% 1015
2023
Q4
$3.23M Buy
326,086
+163,413
+100% +$1.2M 0.01% 1058
2023
Q3
$1.09M Sell
162,673
-33,901
-17% -$261K ﹤0.01% 1470
2023
Q2
$1.47M Buy
+196,574
New +$1.2M ﹤0.01% 1553
2022
Q1
– Sell
-11,298
Closed -$107K – 4189
2021
Q4
$107K Hold
11,298
– – ﹤0.01% 3362
2021
Q3
$382K Buy
32,493
+22,151
+214% +$321K ﹤0.01% 2536
2021
Q2
$199K Buy
+10,342
New +$221K ﹤0.01% 2446
2021
Q1
– Sell
-18,383
Closed -$521K – 2946
2020
Q4
$521K Sell
18,383
-43,764
-70% -$1.2M ﹤0.01% 1439
2020
Q3
$1.95M Sell
62,147
-3,324
-5% -$108K 0.01% 813
2020
Q2
$2.07M Buy
+65,471
New +$1.91M 0.01% 776
2019
Q2
– Sell
-3,940
Closed -$90K – 1941
2019
Q1
$90K Sell
3,940
-24,066
-86% -$632K ﹤0.01% 1455
2018
Q4
$707K Buy
+28,006
New +$735K 0.01% 1007

Other funds holding MOR

Marshall Wace's MOR Position: Q2 2024 in Review

Marshall Wace sold out of MorphoSys (MOR) in Q2 2024, closing a stake of 264,961 shares — an estimated $4.81M sold.

Marshall Wace first reported a position in MOR in Q4 2018 and held it in 12 quarters. The position peaked at $4.81M in Q1 2024. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Marshall Wace reported no remaining MorphoSys position as of Q2 2024 after selling out during the quarter.
  • Marshall Wace sold 264,961 MorphoSys shares in Q2 2024, an estimated $4.81M.
  • Marshall Wace first reported a position in MorphoSys in Q4 2018 and held it in 12 quarters.
  • Marshall Wace's MorphoSys position peaked at $4.81M in Q1 2024.
  • 26 funds tracked by Wall St. Rank held MorphoSys as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.